The independent medical news service

The Taiwan Lung Cancer Screening in Never-Smoker Trial suggests that low-dose computed tomography screening may help to detect early-stage disease in never smokers at high risk for developing lung cancer.

Non-small-cell lung cancer survival after complete resection was not improved by use of mRNA expression levels of two genes to guide choice of adjuvant chemotherapy, shows research reported at the IASLC 2020 World Conference on Lung Cancer.

Read more about this US FDA decision here

Promising early data on several novel treatment options for non-small-cell lung cancer harboring rare EGFR alterations have been reported at the IASLC 2020 World Conference on Lung Cancer.

AMG 757, a half-life extended, bispecific T-cell engager immunotherapy directed against DLL3, has demonstrated tolerability and antitumor activity in patients with previously treated small-cell lung cancer in a phase 1 trial.

Two cycles of neoadjuvant atezolizumab may benefit patients with resectable non-small-cell lung cancer, indicate findings from the LCMC3 study presented at the IASLC 2020 World Conference on Lung Cancer.